Ohcanbohtosat - Jonathan Webster

  • Čájehuvvo 1 - 13 / 13
Aiddostahte ozu
  1. 1
    Acute myeloid leukemia in the elderly: therapeutic options and choice

    Acute myeloid leukemia in the elderly: therapeutic options and choice Dahkki Jonathan Webster, Keith W. Pratz

    Almmustuhtton 2017
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Hyperthyroidism and human chorionic gonadotrophin production in gestational trophoblastic disease

    Hyperthyroidism and human chorionic gonadotrophin production in gestational trophoblastic disease Dahkki Lucy Walkington, Jonathan Webster, B. W. Hancock, Jan Everard, Robert E. Coleman

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Mobile app validation: a digital health scorecard approach

    Mobile app validation: a digital health scorecard approach Dahkki Ramy Sedhom, Michael McShea, Adam B. Cohen, Jonathan Webster, Simon C. Mathews

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    A Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic Amenorrhea

    A Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic Amenorrhea Dahkki Jonathan Webster, G. Piscitelli, Anna Polli, Carlo Ferrari, Ikram Shah Ismail, M. F. Scanlon

    Almmustuhtton 1994
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion.

    Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion. Dahkki Sadanori Akita, Jonathan Webster, Shaolei Ren, Hirofumi Takino, Joanne Said, O Zand, Шломо Мелмед

    Almmustuhtton 1995
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    DNA methyltransferase inhibitor exposure–response: Challenges and opportunities

    DNA methyltransferase inhibitor exposure–response: Challenges and opportunities Dahkki Amanda B. Kagan, Dominique A. Garrison, Nicole M. Anders, Jonathan Webster, Sharyn D. Baker, Srinivasan Yegnasubramanian, Michelle A. Rudek

    Almmustuhtton 2023
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Hydroxylated chalcones with dual properties: Xanthine oxidase inhibitors and radical scavengers

    Hydroxylated chalcones with dual properties: Xanthine oxidase inhibitors and radical scavengers Dahkki Emily Hofmann, Jonathan Webster, Thuy Do, Reid Kline, Lindsey Snider, Quintin Hauser, Grace Higginbottom, Austin Campbell, Lili Ma, Stefan Paula

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ

    Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ Dahkki Mimansa Sharma, Andrew H. Beck, Jonathan Webster, I Espinosa, Kelli Montgomery, Sushama Varma, Matt van de Rijn, Kristin C. Jensen, Robert B. West

    Almmustuhtton 2009
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Chaperone Activity of Small Heat Shock Proteins Underlies Therapeutic Efficacy in Experimental Autoimmune Encephalomyelitis

    Chaperone Activity of Small Heat Shock Proteins Underlies Therapeutic Efficacy in Experimental Autoimmune Encephalomyelitis Dahkki Michael Kurnellas, Sara E. Brownell, Leon Su, Andrey V. Malkovskiy, Jayakumar Rajadas, Gregory Dolganov, Sidharth Chopra, Gary K. Schoolnik, Raymond A. Sobel, Jonathan Webster, Shalina S. Ousman, Rachel A. Becker, Lawrence Steinman, Jonathan B. Rothbard

    Almmustuhtton 2012
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Pattern of Frequent But Nontargeted Pharmacologic Thromboprophylaxis for Hospitalized Patients With Cancer at Academic Medical Centers: A Prospective, Cross-Sectional, Multicenter Study

    Pattern of Frequent But Nontargeted Pharmacologic Thromboprophylaxis for Hospitalized Patients With Cancer at Academic Medical Centers: A Prospective, Cross-Sectional, Multicenter... Dahkki Jeffrey I. Zwicker, Adam Rojan, Federico Campigotto, Nadia Rehman, Renee Funches, Gregory C. Connolly, Jonathan Webster, Anita Aggarwal, Dalia Mobarek, Charles Faselis, Donna Neuberg, Frederick R. Rickles, Ted Wun, Michael B. Streiff, Alok A. Khorana

    Almmustuhtton 2014
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia

    Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia Dahkki Jonathan Webster, Raoul Tibes, Larry Morris, Amanda L. Blackford, Mark R. Litzow, Mrinal M. Patnaik, Gary L. Rosner, Ivana Gojo, Robert J. Kinders, Lihua Wang, L. Austin Doyle, Catherine J. Huntoon, Larry M. Karnitz, Scott H. Kaufmann, Judith E. Karp, B. Douglas Smith

    Almmustuhtton 2017
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Multi-Center Phase 2 Study of Pembroluzimab (Pembro) and Azacitidine (AZA) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) and in Newly Diagnosed (≥65 Years) AML Patients

    Multi-Center Phase 2 Study of Pembroluzimab (Pembro) and Azacitidine (AZA) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) and in Newly Diagnosed (≥65 Years) AML... Dahkki Ivana Gojo, Robert K. Stuart, Jonathan Webster, Amanda L. Blackford, Juan Carlos Varela, Jillian Morrow, Amy E. DeZern, Matthew C. Foster, Mark J. Levis, Catherine C. Coombs, Gabrielle T. Prince, B. Douglas Smith, Hendrik W. van Deventer, Katarzyna Jamieson, Ravi Varadhan, Benjamin G. Vincent, Jonathan S. Serody, Leo Luznik, Joshua F. Zeidner

    Almmustuhtton 2019
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia

    Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia Dahkki Joshua F. Zeidner, Benjamin G. Vincent, Anastasia Ivanova, Dominic T. Moore, Karen P. McKinnon, Alec Wilkinson, Rupkatha Mukhopadhyay, Francesco Mazziotta, Hanna A. Knaus, Matthew C. Foster, Catherine C. Coombs, Katarzyna Jamieson, Hendrik Van Deventer, Jonathan Webster, Gabrielle T. Prince, Amy E. DeZern, B. Douglas Smith, Mark J. Levis, Nathan D. Montgomery, Leo Luznik, Jonathan S. Serody, Ivana Gojo

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: